Hemab Therapeutics Holdings, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 26 | Q2 26 |
|---|---|---|
| – | +166.9% | |
| – | +173.9% | |
| – | +376.1% | |
| – | +179.7% | |
| – | – | |
| – | -96.4% | |
| – | -1.9% | |
| – | -15.4% | |
| – | +9.7% | |
| – | – | |
| – | – | |
| – | -31.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.